Rege Nephro is Drug Discovery in Japan that focus on stem cells business. Founded in 2019. They cover business area such as developer, therapeutic drug, patient, renal failure, core seed technology, pluripotent stem cell, erythropoietin, EPO, ureteral blast cell, surface marker, nephron progenitor cell, doctor, dialysis.
2019
( 5 years old in 2024 )
Stem Cells
-
MIC building, Graduate School of Medicine, Kyoto University
53 Kawahara-cho, Shogoin, Sakyo-ku
Kyoto, 606-8507
Japan
Private
developertherapeutic drugpatientrenal failurecore seed technologypluripotent stem cellerythropoietinEPOureteral blast cellsurface markernephron progenitor celldoctordialysis
* We use standard office opening hours in near Rege Nephro's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rege Nephro is Drug Discovery business from Japan that founded in 2019 (5 years old in 2024), Rege Nephro business is focusing on Stem Cells.
Rege Nephro headquarter office and corporate office address is located in MIC building, Graduate School of Medicine, Kyoto University 53 Kawahara-cho, Shogoin, Sakyo-ku Kyoto, 606-8507 Japan.
Rege Nephro was founded in Japan.
In 2024, Rege Nephro is currently focus on stem cells sector.
Above is snippet of Google Trends for "stem cells" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rege Nephro, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
